List of works - Giancarlo Pruneri

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.

scientific article published on 11 February 2017

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

scientific article published on 13 January 2009

Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.

scientific article

Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

scientific article published on 01 December 2007

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

scientific article published on 16 March 2006

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

scientific article published in July 2006

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

scientific article published on 5 August 2013

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

article

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

scientific article published on 31 August 2010

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

scientific article published on 24 October 2012

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

scientific article

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

scientific article

Immunohistochemically defined subtypes and outcome of apocrine breast cancer

scientific article

Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis

article

In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue

scientific article published on 01 August 2002

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

scientific article

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

scientific article

Lymph node metastases of Merkel cell carcinoma from unknown primary site: report of three cases

scientific article published on 01 September 2008

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

scientific article published on 01 September 2002

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

scientific article published on 28 April 2010

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

scientific article published on 18 July 2007

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

scientific article published on 13 July 2010

Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?

scientific article published on 30 September 2013

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

scientific article

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study

scientific article

Syk expression patterns differ among B-cell lymphomas

scientific article published on 07 April 2010

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.

scientific article published on 02 July 2016

List of works by Giancarlo Pruneri

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

Cell cycle regulators in multiple myeloma: prognostic implications of p53 nuclear accumulation.

Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas

Complementary populations of human adipose CD34+ progenitor cells promote growth, angiogenesis, and metastasis of breast cancer.

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

Genomic lesions associated with a different clinical outcome in diffuse large B-Cell lymphoma treated with R-CHOP-21.

Heterogeneity of triple-negative breast cancer: histologic subtyping to inform the outcome.

Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

If it is in the marrow, is it also in the blood? An analysis of 1,000 paired samples from patients with B-cell non-Hodgkin lymphoma.

Immunohistochemically defined subtypes and outcome of apocrine breast cancer

Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis

In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue

In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.

Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy

Lymph node metastases of Merkel cell carcinoma from unknown primary site: report of three cases

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

Non-negative matrix factorization to perform unsupervised clustering of genome wide DNA profiles in mature B cell lymphoid neoplasms

Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression

Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features

Pathological features and survival outcomes of very young patients with early breast cancer: how much is "very young"?

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study

Syk expression patterns differ among B-cell lymphomas

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.